Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Abbott Laboratories (NYSE: ABT) closed at $104.94 in the last session, down -1.16% from day before closing price of $106.17. In other words, the price has decreased by -$1.16 from its previous closing price. On the day, 6.2 million shares were traded. ABT stock price reached its highest trading level at $106.34 during the session, while it also had its lowest trading level at $104.28.
Ratios:
We take a closer look at ABT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 27.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.08. For the most recent quarter (mrq), Quick Ratio is recorded 1.11 and its Current Ratio is at 1.60. In the meantime, Its Debt-to-Equity ratio is 0.38 whereas as Long-Term Debt/Eq ratio is at 0.32.
On May 30, 2023, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $112.
Wolfe Research reiterated its Underperform rating for the stock on April 20, 2023, while the target price for the stock was revised from $107 to $103.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 07 ’24 when Earnhardt Lisa D sold 22,852 shares for $106.25 per share. The transaction valued at 2,428,119 led to the insider holds 61,462 shares of the business.
Salvadori Daniel Gesua Sive sold 963 shares of ABT for $114,116 on Mar 01 ’24. The EXECUTIVE VICE PRESIDENT now owns 125,697 shares after completing the transaction at $118.50 per share. On Mar 01 ’24, another insider, ALLEN HUBERT L, who serves as the EXECUTIVE VICE PRESIDENT of the company, sold 853 shares for $118.50 each. As a result, the insider received 101,080 and left with 184,806 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABT now has a Market Capitalization of 182556770304 and an Enterprise Value of 192983990272. As of this moment, Abbott’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.69, and their Forward P/E ratio for the next fiscal year is 20.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.53 while its Price-to-Book (P/B) ratio in mrq is 4.70. Its current Enterprise Value per Revenue stands at 4.786 whereas that against EBITDA is 18.613.
Stock Price History:
Over the past 52 weeks, ABT has reached a high of $121.64, while it has fallen to a 52-week low of $89.67. The 50-Day Moving Average of the stock is -6.42%, while the 200-Day Moving Average is calculated to be -1.55%.
Shares Statistics:
According to the various share statistics, ABT traded on average about 5.62M shares per day over the past 3-months and 4188060 shares per day over the past 10 days. A total of 1.73B shares are outstanding, with a floating share count of 1.73B. Insiders hold about 0.73% of the company’s shares, while institutions hold 76.72% stake in the company. Shares short for ABT as of 1713139200 were 12937099 with a Short Ratio of 2.30, compared to 1710460800 on 15715789. Therefore, it implies a Short% of Shares Outstanding of 12937099 and a Short% of Float of 0.75.
Dividends & Splits
The forward annual dividend rate for ABT is 2.12, which was 2.12 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.019967975The stock’s 5-year Average Dividend Yield is 1.6.
